Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Midcap Earnings Wisdomtree	EZM	5. nov 2024	62.66	+1.55
Midcap ETF Vanguard	VO	5. nov 2024	266.69	+1.57
MidCap Financial Investment	MFIC	5. nov 2024	13.21	+0.53
Midcap Growth Alphadex First Trust	FNY	5. nov 2024	81.18	+1.71
Midcap Growth ETF Vanguard	VOT	5. nov 2024	249.63	+1.92
Midcap Value Alphadex First Trust	FNK	5. nov 2024	53.91	+1.37
Midcap Value ETF Vanguard	VOE	5. nov 2024	167.54	+1.31
Middleby	MIDD	5. nov 2024	137.09	+2.20
Middlefield Banc	MBCN	5. nov 2024	29.84	+3.94
Middlesex Water	MSEX	5. nov 2024	66.85	+4.01
Midland States Bancorp	MSBI	5. nov 2024	24.99	+1.92
Midland States Bancorp Pref A	MSBIP	5. nov 2024	25.05	-0.36
MidWestOne Financial Group	MOFG	5. nov 2024	29.24	+2.81
Milestone Pharmaceuticals	MIST	5. nov 2024	1.59	+7.43
Milestone Scientific	MLSS	5. nov 2024	0.80	-1.10
Mill City Ventures	MCVT	5. nov 2024	2.07	-5.48
Millennium Group International	MGIH	5. nov 2024	1.51	0.00
Miller Industries	MLR	5. nov 2024	69.18	+3.16
Miller/Howard High Income Equity Fund	HIE	5. nov 2024	12.27	+0.90
MillerKnoll	MLKN	5. nov 2024	23.47	+1.29
Millicom International Cellular	TIGO	5. nov 2024	27.32	+1.64
MiMedx Group	MDXG	5. nov 2024	7.29	+2.24
MIND C.T.I.	MNDO	5. nov 2024	1.95	-0.78
Mind Technology	MIND	5. nov 2024	3.57	-1.11
MindMed	MNMD	5. nov 2024	6.15	+1.49
Minerals Technologies	MTX	5. nov 2024	77.19	+1.57
Mineralys Therapeutics	MLYS	5. nov 2024	13.51	+0.07
Minerva Neurosciences	NERV	5. nov 2024	2.36	+1.72
Mingteng International	MTEN	5. nov 2024	5.05	-1.17
MingZhu Logistics	YGMZ	5. nov 2024	1.33	+7.26

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.